| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0005 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |